Symbiotec Pharmalab Ltd. Listed
Incorporated in 2002, Symbiotec Pharmalab Ltd. is a pharmaceutical and biotechnology company engaged in the development and manufacturing of active pharmaceutical ingredients (APIs), nutritional ingredients, and...
GREY MARKET PREMIUM
+₹285
▲ +28.85% vs issue price
Issue Price
₹988.00
Est. Listing Price
₹1,273.00
Lot Size
15
Issue Details
Open Date
2026-08-24
Close Date
2026-08-27
Allotment
2026-08-28
Face Value
₹2.00
Total Issue Size
1,77,86,442 shares (agg. up to ₹1,757 Cr) Cr
Issue Type
Mainboard
Exchange
NSE & BSE
Subscription Status
| Category | Subscription (x) | Shares Offered | Shares Bid |
|---|---|---|---|
| QIB | 72.96x | 8876516.00 | 647629440.00 |
| NII (HNI) | 77.22x | 2662956.00 | 205638555.00 |
| Retail | 13.42x | 6213563.00 | 83371905.00 |
| Market Maker | 1x | - | - |
| Total | 1.53x | 33407.00 | 50970.00 |
Financials (₹ Cr)
| Period | Revenue | PAT | EBITDA | Net Worth |
|---|---|---|---|---|
| 31 Mar 2026 | 872.26 | 109.90 | 231.97 | 1158.64 |
| 31 Mar 2025 | 755.98 | 96.79 | 206.11 | 821.15 |
| 31 Mar 2024 | 723.33 | 100.06 | 177.04 | 720.68 |
Key Ratios
Return on Equity
12.66
Return on Capital Employed
11.80
Return on Net Worth
11.79
PAT / Revenue
12.80
EBITDA / Revenue
27.26
Price to Book Value
150.17
Objects of the Issue
- Prepayment and/or repayment, in full or in part, of all or a portion of certain outstanding borrowings availed by the Company — ₹112.50 Cr
- General corporate purposes
Lead Managers
JM Financial Ltd
Avendus Capital Pvt.Ltd
Motilal Oswal Investment Advisors Ltd.
Nomura Financial Advisory & Securities (India) Pvt.Ltd.
Compare GMP Across IPOs
See how this IPO's GMP stacks up against every other live IPO.
Open GMP Charts →